Spectral Medical Inc
TSX:EDT
Spectral Medical Inc
Revenue
Spectral Medical Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Spectral Medical Inc
TSX:EDT
|
Revenue
CA$1.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-5%
|
|
Zymeworks Inc
NYSE:ZYME
|
Revenue
$76m
|
CAGR 3-Years
25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Revenue
$78.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Revenue
$51.1m
|
CAGR 3-Years
700%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Revenue
$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Revenue
$175.5m
|
CAGR 3-Years
52%
|
CAGR 5-Years
223%
|
CAGR 10-Years
68%
|
See Also
What is Spectral Medical Inc's Revenue?
Revenue
1.6m
CAD
Based on the financial report for Dec 31, 2023, Spectral Medical Inc's Revenue amounts to 1.6m CAD.
What is Spectral Medical Inc's Revenue growth rate?
Revenue CAGR 10Y
-5%
Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Spectral Medical Inc have been -9% over the past three years , -16% over the past five years , and -5% over the past ten years .